25 04, 2017

CVR Medical Provides Update on its Thomas Jefferson University Clinical Trials

By | April 25th, 2017|Press Release|0 Comments

VANCOUVER, BC / ACCESSWIRE / April 25, 2017 / CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces update on clinical trials of the “Carotid Stenotic Scan (CSS),” currently being conducted through the Jefferson Clinical Research Institute at Thomas Jefferson University under the supervision of Dr. David J. Whellan. “Enrollment was initiated in early [...]

24 04, 2017

CVR Medical Announces Closing of Second Tranche of Financing

By | April 24th, 2017|Press Release|0 Comments

VANCOUVER, BC / ACCESSWIRE / April 24, 2017 / CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to report that it has closed the second and final tranche (the "Second Tranche") of its previously announced non-brokered private placement financing (the "Financing"). As previously announced, an aggregate of 7,521,768 units ("Units") at a [...]

20 04, 2017

CVR Medical Announces Closing of First Tranche of Financing

By | April 20th, 2017|Press Release|0 Comments

VANCOUVER, BC / ACCESSWIRE / April 20, 2017 / CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to report that it has closed the first tranche (the "First Tranche") of its previously announced non-brokered private placement financing (the "Financing"). An aggregate of 7,521,768 units ("Units") at a price of $0.48 per Unit [...]